News Image

Why NYSE:DGX provides a good dividend, while having solid fundamentals.

By Mill Chart

Last update: Mar 19, 2024

Consider QUEST DIAGNOSTICS INC (NYSE:DGX) as a top pick for dividend investors, identified by our stock screening tool. NYSE:DGX shines in terms of profitability, solvency, and liquidity, all while paying a decent dividend. Let's dive deeper into the analysis.

ChartMill's Evaluation of Dividend

ChartMill employs its own Dividend Rating system for all stocks. This score, on a scale of 0 to 10, is determined by evaluating different dividend factors, such as yield, historical performance, dividend growth, and sustainability. NYSE:DGX has been assigned a 7 for dividend:

  • Compared to an average industry Dividend Yield of 2.67, DGX pays a better dividend. On top of this DGX pays more dividend than 92.24% of the companies listed in the same industry.
  • The dividend of DGX is nicely growing with an annual growth rate of 7.50%!
  • DGX has paid a dividend for at least 10 years, which is a reliable track record.
  • DGX has not decreased their dividend for at least 10 years, which is a reliable track record.
  • DGX pays out 36.94% of its income as dividend. This is a sustainable payout ratio.

Health Assessment of NYSE:DGX

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:DGX has earned a 5 out of 10:

  • DGX has an Altman-Z score of 2.99. This indicates that DGX is financially healthy and has little risk of bankruptcy at the moment.
  • DGX has a Altman-Z score of 2.99. This is in the better half of the industry: DGX outperforms 75.86% of its industry peers.
  • DGX has a Debt to FCF ratio of 5.45. This is in the better half of the industry: DGX outperforms 69.83% of its industry peers.

A Closer Look at Profitability for NYSE:DGX

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:DGX has earned a 8 out of 10:

  • DGX has a Return On Assets of 6.06%. This is amongst the best in the industry. DGX outperforms 84.48% of its industry peers.
  • The Return On Equity of DGX (13.48%) is better than 81.90% of its industry peers.
  • The Return On Invested Capital of DGX (8.26%) is better than 80.17% of its industry peers.
  • DGX had an Average Return On Invested Capital over the past 3 years of 11.72%. This is above the industry average of 8.60%.
  • DGX has a better Profit Margin (9.19%) than 92.24% of its industry peers.
  • DGX's Operating Margin of 13.91% is amongst the best of the industry. DGX outperforms 93.10% of its industry peers.
  • With a decent Gross Margin value of 33.14%, DGX is doing good in the industry, outperforming 60.34% of the companies in the same industry.

Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.

Our latest full fundamental report of DGX contains the most current fundamental analsysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

QUEST DIAGNOSTICS INC

NYSE:DGX (4/25/2024, 6:45:41 PM)

After market: 135.42 0 (0%)

135.42

-2.13 (-1.55%)

DGX News

News Image2 days ago - ChartmillWondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

News Image2 days ago - InvestorPlaceDGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024

DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image2 days ago - Market News VideoS&P 500 Movers: MSCI, DGX
News Image2 days ago - ChartmillWhat's going on in today's pre-market session: S&P500 movers

The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

News Image3 days ago - Quest DiagnosticsQuest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the...

News Image4 days ago - Quest DiagnosticsQuest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new blood biomarker test for...

News Image7 days ago - Market News VideoLiberty Media Larger Than S&P 500 Component Quest Diagnostics
News Image16 days ago - ChartmillBalancing Dividends and Fundamentals: The Case of NYSE:DGX.

Uncovering Dividend Opportunities with QUEST DIAGNOSTICS INC (NYSE:DGX).

News Image24 days ago - Quest DiagnosticsQuest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay

/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Broad Clinical Labs, the world expert in whole genome...

News Imagea month ago - Quest DiagnosticsStudy in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease

/PRNewswire/ -- A blood test that analyzes levels of amyloid proteins by highly sensitive mass spectrometry could help physicians establish that Alzheimer's...

News Imagea month ago - Quest DiagnosticsQuest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024...

DGX Links
Follow us for more